Ipamorelin

Description

Ipamorelin

Ipamorelin is a research-grade synthetic pentapeptide studied for its role as a selective growth hormone secretagogue. It is commonly used in experimental models examining pulsatile growth hormone release, recovery-related signaling, body composition research, and endocrine pathway activity.

Ipamorelin acts through the ghrelin receptor, also known as GHSR-1a, where it is investigated for its ability to stimulate endogenous growth hormone secretion while maintaining a more selective hormonal profile compared to earlier growth hormone secretagogues.

Growth Hormone & Endocrine Research

Ipamorelin is frequently studied for its dose-dependent influence on growth hormone release. Research models have evaluated its activity in relation to:

• Pulsatile GH secretion
• IGF-1 pathway activity
• Lean mass research
• Fat metabolism studies
• Endocrine signaling
• Body composition models

Unlike some earlier secretagogues, Ipamorelin has been explored for its selective activity with limited observed influence on cortisol, ACTH, prolactin, FSH, LH, and TSH levels in certain research settings.

Recovery & Performance Research

Ipamorelin is also investigated in models focused on recovery, repair, and performance-related physiology. Areas of interest include:

• Protein synthesis signaling
• Muscle recovery studies
• Connective tissue support research
• Tendon and ligament repair models
• Sleep quality and recovery parameters
• Age-related endocrine function studies

Its selective profile makes it a compound of interest in research involving growth hormone modulation without broad disruption of other hormonal pathways.

Disclaimer

For laboratory research use only.
Not intended for human consumption, therapeutic use, or medical application.

Research Information

For additional scientific information regarding this compound, please refer to our complete research guide.